Cargando…
Serum leucine-rich alpha-2 glycoprotein levels for predicting active ultrasonographic findings in intestinal lesions of patients with Crohn’s disease in clinical remission
This study aimed to investigate the cutoff value of leucine-rich alpha-2 glycoprotein (LRG) in predicting active intestinal ultrasonography (IUS) findings in patients with Crohn’s disease (CD) in clinical remission. Data were retrospectively collected from patients with CD evaluated using LRG and un...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419375/ https://www.ncbi.nlm.nih.gov/pubmed/37565885 http://dx.doi.org/10.1097/MD.0000000000034628 |
_version_ | 1785088502666362880 |
---|---|
author | Nasuno, Masanao Shimazaki, Hiroshi Nojima, Masanori Hamada, Takahito Sugiyama, Kohei Miyakawa, Maki Tanaka, Hiroki |
author_facet | Nasuno, Masanao Shimazaki, Hiroshi Nojima, Masanori Hamada, Takahito Sugiyama, Kohei Miyakawa, Maki Tanaka, Hiroki |
author_sort | Nasuno, Masanao |
collection | PubMed |
description | This study aimed to investigate the cutoff value of leucine-rich alpha-2 glycoprotein (LRG) in predicting active intestinal ultrasonography (IUS) findings in patients with Crohn’s disease (CD) in clinical remission. Data were retrospectively collected from patients with CD evaluated using LRG and undergoing IUS from September 2020 to August 2022. Patients with a Harvey–Bradshaw Index of ≤4 were included and those who underwent intestinal resection were excluded. Bowel wall thickness and stratification and blood flow signal using superb microvascular imaging (SMI) were used to assess ultrasonography findings. SMI signals were categorized into 4 grades following the Limberg score. Receiver operating characteristic curves were constructed and the area under the curve was calculated to determine the LRG cutoff values for predicting active IUS findings and were compared with those of C-reactive protein. This study included 213 patients. The LRG cutoff values to predict active bowel wall thickness, loss of bowel wall stratification, and SMI of ≥1, ≥2, and 3 were 14.6 μg/mL, 14.6 μg/mL, 14.6 μg/mL, 14.6 μg/mL, and 16.9 μg/mL, respectively, with significantly higher areas under the curve in SMI of ≥1 and 3 than in C-reactive protein. The best LRG cutoff value for predicting active IUS findings was 14.6 μg/mL in patients with CD in clinical remission, suggesting that LRG is better than C-reactive protein for detecting active IUS findings in CD. |
format | Online Article Text |
id | pubmed-10419375 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104193752023-08-12 Serum leucine-rich alpha-2 glycoprotein levels for predicting active ultrasonographic findings in intestinal lesions of patients with Crohn’s disease in clinical remission Nasuno, Masanao Shimazaki, Hiroshi Nojima, Masanori Hamada, Takahito Sugiyama, Kohei Miyakawa, Maki Tanaka, Hiroki Medicine (Baltimore) 4500 This study aimed to investigate the cutoff value of leucine-rich alpha-2 glycoprotein (LRG) in predicting active intestinal ultrasonography (IUS) findings in patients with Crohn’s disease (CD) in clinical remission. Data were retrospectively collected from patients with CD evaluated using LRG and undergoing IUS from September 2020 to August 2022. Patients with a Harvey–Bradshaw Index of ≤4 were included and those who underwent intestinal resection were excluded. Bowel wall thickness and stratification and blood flow signal using superb microvascular imaging (SMI) were used to assess ultrasonography findings. SMI signals were categorized into 4 grades following the Limberg score. Receiver operating characteristic curves were constructed and the area under the curve was calculated to determine the LRG cutoff values for predicting active IUS findings and were compared with those of C-reactive protein. This study included 213 patients. The LRG cutoff values to predict active bowel wall thickness, loss of bowel wall stratification, and SMI of ≥1, ≥2, and 3 were 14.6 μg/mL, 14.6 μg/mL, 14.6 μg/mL, 14.6 μg/mL, and 16.9 μg/mL, respectively, with significantly higher areas under the curve in SMI of ≥1 and 3 than in C-reactive protein. The best LRG cutoff value for predicting active IUS findings was 14.6 μg/mL in patients with CD in clinical remission, suggesting that LRG is better than C-reactive protein for detecting active IUS findings in CD. Lippincott Williams & Wilkins 2023-08-11 /pmc/articles/PMC10419375/ /pubmed/37565885 http://dx.doi.org/10.1097/MD.0000000000034628 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. |
spellingShingle | 4500 Nasuno, Masanao Shimazaki, Hiroshi Nojima, Masanori Hamada, Takahito Sugiyama, Kohei Miyakawa, Maki Tanaka, Hiroki Serum leucine-rich alpha-2 glycoprotein levels for predicting active ultrasonographic findings in intestinal lesions of patients with Crohn’s disease in clinical remission |
title | Serum leucine-rich alpha-2 glycoprotein levels for predicting active ultrasonographic findings in intestinal lesions of patients with Crohn’s disease in clinical remission |
title_full | Serum leucine-rich alpha-2 glycoprotein levels for predicting active ultrasonographic findings in intestinal lesions of patients with Crohn’s disease in clinical remission |
title_fullStr | Serum leucine-rich alpha-2 glycoprotein levels for predicting active ultrasonographic findings in intestinal lesions of patients with Crohn’s disease in clinical remission |
title_full_unstemmed | Serum leucine-rich alpha-2 glycoprotein levels for predicting active ultrasonographic findings in intestinal lesions of patients with Crohn’s disease in clinical remission |
title_short | Serum leucine-rich alpha-2 glycoprotein levels for predicting active ultrasonographic findings in intestinal lesions of patients with Crohn’s disease in clinical remission |
title_sort | serum leucine-rich alpha-2 glycoprotein levels for predicting active ultrasonographic findings in intestinal lesions of patients with crohn’s disease in clinical remission |
topic | 4500 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419375/ https://www.ncbi.nlm.nih.gov/pubmed/37565885 http://dx.doi.org/10.1097/MD.0000000000034628 |
work_keys_str_mv | AT nasunomasanao serumleucinerichalpha2glycoproteinlevelsforpredictingactiveultrasonographicfindingsinintestinallesionsofpatientswithcrohnsdiseaseinclinicalremission AT shimazakihiroshi serumleucinerichalpha2glycoproteinlevelsforpredictingactiveultrasonographicfindingsinintestinallesionsofpatientswithcrohnsdiseaseinclinicalremission AT nojimamasanori serumleucinerichalpha2glycoproteinlevelsforpredictingactiveultrasonographicfindingsinintestinallesionsofpatientswithcrohnsdiseaseinclinicalremission AT hamadatakahito serumleucinerichalpha2glycoproteinlevelsforpredictingactiveultrasonographicfindingsinintestinallesionsofpatientswithcrohnsdiseaseinclinicalremission AT sugiyamakohei serumleucinerichalpha2glycoproteinlevelsforpredictingactiveultrasonographicfindingsinintestinallesionsofpatientswithcrohnsdiseaseinclinicalremission AT miyakawamaki serumleucinerichalpha2glycoproteinlevelsforpredictingactiveultrasonographicfindingsinintestinallesionsofpatientswithcrohnsdiseaseinclinicalremission AT tanakahiroki serumleucinerichalpha2glycoproteinlevelsforpredictingactiveultrasonographicfindingsinintestinallesionsofpatientswithcrohnsdiseaseinclinicalremission |